356 related articles for article (PubMed ID: 26517360)
1. Interpretation of cytogenetic results in multiple myeloma for clinical practice.
Rajan AM; Rajkumar SV
Blood Cancer J; 2015 Oct; 5(10):e365. PubMed ID: 26517360
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myeloma.
He J; Yang L; Meng X; Wei G; Wu W; Han X; Zheng G; Zheng W; Ye X; Shi J; Xie W; Zhang J; Huang H; Lin M; Cai Z
Am J Med Sci; 2013 Feb; 345(2):88-93. PubMed ID: 22986611
[TBL] [Abstract][Full Text] [Related]
3. Prediction of cytogenetic abnormalities with gene expression profiles.
Zhou Y; Zhang Q; Stephens O; Heuck CJ; Tian E; Sawyer JR; Cartron-Mizeracki MA; Qu P; Keller J; Epstein J; Barlogie B; Shaughnessy JD
Blood; 2012 May; 119(21):e148-50. PubMed ID: 22496154
[TBL] [Abstract][Full Text] [Related]
4. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
[TBL] [Abstract][Full Text] [Related]
5. Sequential analysis of chromosome aberrations in multiple myeloma during disease progression.
Wu KL; Beverloo B; Velthuizen SJ; Sonneveld P
Clin Lymphoma Myeloma; 2007 Jan; 7(4):280-5. PubMed ID: 17324335
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenetic study on 53 patients with multiple myeloma].
Jing Y; Fang MY; Jiang F; Lin S; Wang FT
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):68-72. PubMed ID: 21362224
[TBL] [Abstract][Full Text] [Related]
7. [Molecular cytogenetic analyses of patients with plasma cell myeloma in Tolna and Baranya counties in Hungary].
Kosztolányi S; Horváth B; Hosnyánszki D; Kereskai L; Sziládi E; Jáksó P; Alizadeh H; Szuhai K; Alpár D; Kajtár B
Orv Hetil; 2019 Jun; 160(24):944-951. PubMed ID: 31433233
[TBL] [Abstract][Full Text] [Related]
8. [High risk cytogenetic abnormalities in patients with multiple myeloma].
Legües ME; Morales P; Valenzuela M; Encina A; Martí MJ; Bascuñán C; Cornejo P; Peña C; Undurraga MS
Rev Med Chil; 2019; 147(1):61-64. PubMed ID: 30848766
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma.
Merz M; Hielscher T; Schult D; Mai EK; Raab MS; Hillengass J; Seckinger A; Hose D; Granzow M; Jauch A; Goldschmidt H
Leukemia; 2020 Apr; 34(4):1192-1196. PubMed ID: 31712777
[No Abstract] [Full Text] [Related]
10. Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.
Greenberg AJ; Rajkumar SV; Therneau TM; Singh PP; Dispenzieri A; Kumar SK
Leukemia; 2014 Feb; 28(2):398-403. PubMed ID: 24005246
[TBL] [Abstract][Full Text] [Related]
11. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.
Alpar D; de Jong D; Holczer-Nagy Z; Kajtar B; Savola S; Jakso P; David M; Kosztolanyi S; Kereskai L; Pajor L; Szuhai K
Genes Chromosomes Cancer; 2013 Sep; 52(9):785-93. PubMed ID: 23720363
[TBL] [Abstract][Full Text] [Related]
12. An internationally recognized uniform cytogenetic classification system is needed for multiple myeloma.
Dispenzieri A
Leukemia; 2007 Jan; 21(1):9-11. PubMed ID: 17167528
[No Abstract] [Full Text] [Related]
13. [Cytogenetic study of multiple myeloma].
Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
[TBL] [Abstract][Full Text] [Related]
14. [A modified cytogenetic study for multiple myeloma].
Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic Abnormalities and Outcomes of 117 Patients with Multiple Myeloma Detected by FISH].
Zhai B; Zou DD; Yan JJ; Wang N; Wang LL; Zhu HL; Huang WR; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):127-30. PubMed ID: 26913408
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic abnormalities in multiple myeloma.
Fonseca R; Coignet LJ; Dewald GW
Hematol Oncol Clin North Am; 1999 Dec; 13(6):1169-80, viii. PubMed ID: 10626143
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma.
Rosiñol L; Carrió A; Bladé J; Queralt R; Aymerich M; Cibeira MT; Esteve J; Rozman M; Campo E; Montserrat E
Br J Haematol; 2005 Sep; 130(5):729-32. PubMed ID: 16115129
[TBL] [Abstract][Full Text] [Related]
18. [The significance and current diagnostic options of cytogenetic changes in multiple myeloma].
Kuglík P; Filková H; Oltová A; Hájek R
Vnitr Lek; 2006 Nov; 52 Suppl 2():76-8. PubMed ID: 18175433
[TBL] [Abstract][Full Text] [Related]
19. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
[TBL] [Abstract][Full Text] [Related]
20. International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocols.
Waheed S; Shaughnessy JD; van Rhee F; Alsayed Y; Nair B; Anaissie E; Szymonifka J; Hoering A; Crowley J; Barlogie B
Cancer; 2011 Mar; 117(5):1001-9. PubMed ID: 20945320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
